- Home
- BKU vs APLS Comparison
BKU vs APLS Comparison
Compare BKU & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- APLS
- Stock Information
- Founded
- BKU 2009
- APLS 2009
- Country
- BKU United States
- APLS United States
- Employees
- BKU N/A
- APLS N/A
- Industry
- BKU Savings Institutions
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- BKU Finance
- APLS Health Care
- Exchange
- BKU Nasdaq
- APLS Nasdaq
- Market Cap
- BKU 2.7B
- APLS 2.2B
- IPO Year
- BKU 2011
- APLS 2017
- Fundamental
- Price
- BKU $33.95
- APLS $16.93
- Analyst Decision
- BKU Hold
- APLS Buy
- Analyst Count
- BKU 11
- APLS 19
- Target Price
- BKU $40.36
- APLS $37.50
- AVG Volume (30 Days)
- BKU 767.0K
- APLS 2.9M
- Earning Date
- BKU 07-17-2025
- APLS 05-07-2025
- Dividend Yield
- BKU 3.65%
- APLS N/A
- EPS Growth
- BKU 38.76
- APLS N/A
- EPS
- BKU 3.21
- APLS N/A
- Revenue
- BKU $972,198,000.00
- APLS $775,839,000.00
- Revenue This Year
- BKU $13.53
- APLS $1.54
- Revenue Next Year
- BKU $6.89
- APLS $22.80
- P/E Ratio
- BKU $10.57
- APLS N/A
- Revenue Growth
- BKU 11.13
- APLS 48.04
- 52 Week Low
- BKU $26.78
- APLS $16.10
- 52 Week High
- BKU $44.45
- APLS $43.76
- Technical
- Relative Strength Index (RSI)
- BKU 47.47
- APLS 41.44
- Support Level
- BKU $33.44
- APLS $16.61
- Resistance Level
- BKU $35.04
- APLS $17.48
- Average True Range (ATR)
- BKU 0.71
- APLS 0.86
- MACD
- BKU -0.20
- APLS 0.09
- Stochastic Oscillator
- BKU 16.61
- APLS 28.47
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.